BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24603459)

  • 1. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
    Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
    Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
    Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth.
    Han Y; Demorrow S; Invernizzi P; Jing Q; Glaser S; Renzi A; Meng F; Venter J; Bernuzzi F; White M; Francis H; Lleo A; Marzioni M; Onori P; Alvaro D; Torzilli G; Gaudio E; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2011 Oct; 301(4):G623-33. PubMed ID: 21778461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth.
    Hall C; Ehrlich L; Venter J; O'Brien A; White T; Zhou T; Dang T; Meng F; Invernizzi P; Bernuzzi F; Alpini G; Lairmore TC; Glaser S
    Cancer Lett; 2017 Feb; 386():179-188. PubMed ID: 27894959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
    Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
    Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
    Francis H; Onori P; Gaudio E; Franchitto A; DeMorrow S; Venter J; Kopriva S; Carpino G; Mancinelli R; White M; Meng F; Vetuschi A; Sferra R; Alpini G
    Mol Cancer Res; 2009 Oct; 7(10):1704-13. PubMed ID: 19825989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
    Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
    Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
    Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
    World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway.
    Fava G; Marucci L; Glaser S; Francis H; De Morrow S; Benedetti A; Alvaro D; Venter J; Meininger C; Patel T; Taffetani S; Marzioni M; Summers R; Reichenbach R; Alpini G
    Cancer Res; 2005 Dec; 65(24):11437-46. PubMed ID: 16357152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
    Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
    World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
    Lu D; Han C; Wu T
    Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.
    Francis H; DeMorrow S; Venter J; Onori P; White M; Gaudio E; Francis T; Greene JF; Tran S; Meininger CJ; Alpini G
    Gut; 2012 May; 61(5):753-64. PubMed ID: 21873469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.
    Pan S; Hu Y; Hu M; Xu Y; Chen M; Du C; Cui J; Zheng P; Lai J; Zhang Y; Bai J; Jiang P; Zhu J; He Y; Wang J
    Int J Oncol; 2020 Jan; 56(1):101-112. PubMed ID: 31746424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.
    Onori P; DeMorrow S; Gaudio E; Franchitto A; Mancinelli R; Venter J; Kopriva S; Ueno Y; Alvaro D; Savage J; Alpini G; Francis H
    Int J Cancer; 2009 Aug; 125(3):565-76. PubMed ID: 19358267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.